We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.71%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.3B
AUM Growth
-$783M
(-2.3%)
Cap. Flow
-$715M
Cap. Flow
% of AUM
-2.15%
Top 10 Holdings %
Top 10 Hldgs %
15.9%
Holding
3,039
New
28
Increased
1,056
Reduced
1,268
Closed
57
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$29M |
| 2 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$14M |
| 3 |
Microsoft
MSFT
|
+$10.8M |
| 4 |
Meta Platforms (Facebook)
META
|
+$10.5M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$6.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$34.4M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
+$32.2M |
| 3 |
ExxonMobil
XOM
|
+$23.9M |
| 4 |
Warner Bros
WBD
|
+$15.4M |
| 5 |
RTX Corp
RTX
|
+$13.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.81% |
| 2 | Financials | 14.8% |
| 3 | Healthcare | 13.73% |
| 4 | Industrials | 10.72% |
| 5 | Energy | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Teleflex
TFX
$6.05B
| $5.48M | 0.02% |
52,170
+800
| +2% | +$85.9K |
|
|
SLH
727
DELISTED
SOLERA HOLDINGS, INC. COM
SLH
| $5.48M | 0.02% |
97,179
+427
| +0.4% | +$27K |
|
|
WR
728
DELISTED
Westar Energy Inc
WR
| $5.46M | 0.02% |
160,096
+3,230
| +2% | +$117K |
|
729
Cognex
CGNX
$10.9B
| $5.46M | 0.02% |
271,092
+71,478
| +36% | +$1.48M |
|
730
Lamar Advertising Co
LAMR
$16.2B
| $5.43M | 0.02% |
110,219
+8,752
| +9% | +$451K |
|
731
CNO Financial Group
CNO
$5.14B
| $5.42M | 0.02% |
319,715
+820
| +0.3% | +$14.1K |
|
732
Zebra Technologies
ZBRA
$14B
| $5.42M | 0.02% |
76,360
+477
| +0.6% | +$37.2K |
|
|
DHC
733
Diversified Healthcare Trust
DHC
$2.15B
| $5.41M | 0.02% |
260,707
-1,332
| -0.5% | -$30.2K |
|
|
UMPQ
734
DELISTED
Umpqua Holdings Corp
UMPQ
| $5.38M | 0.02% |
326,731
+6,331
| +2% | +$109K |
|
735
Steris
STE
$22.3B
| $5.38M | 0.02% |
99,611
+1,655
| +2% | +$90K |
|
736
Alkermes
ALKS
$8.22B
| $5.37M | 0.02% |
125,234
-6,723
| -5% | -$301K |
|
737
Cinemark Holdings
CNK
$4.24B
| $5.34M | 0.02% |
157,009
+1,972
| +1% | +$68.4K |
|
738
NewMarket
NEU
$7.82B
| $5.33M | 0.02% |
13,996
+66
| +0.5% | +$26.2K |
|
|
GRA
739
DELISTED
W.R. Grace & Co.
GRA
| $5.3M | 0.02% |
58,339
-1,153
| -2% | -$110K |
|
|
RFMD
740
DELISTED
RF MICRO DEVICES INC
RFMD
| $5.3M | 0.02% |
459,571
+9,570
| +2% | +$108K |
|
|
TIBX
741
DELISTED
TIBCO SOFTWARE INC
TIBX
| $5.29M | 0.02% |
223,678
+1,367
| +0.6% | +$28K |
|
742
Deluxe
DLX
$1.18B
| $5.28M | 0.02% |
95,786
+745
| +0.8% | +$42.9K |
|
|
RAX
743
DELISTED
Rackspace Hosting Inc
RAX
| $5.28M | 0.02% |
162,147
+2,942
| +2% | +$97.6K |
|
744
CoreCivic
CXW
$2.96B
| $5.27M | 0.02% |
153,463
+325
| +0.2% | +$11.2K |
|
|
HNT
745
DELISTED
HEALTH NET INC
HNT
| $5.27M | 0.02% |
114,362
+12,580
| +12% | +$558K |
|
746
Hancock Whitney
HWC
$6.2B
| $5.27M | 0.02% |
164,326
+1,470
| +0.9% | +$49K |
|
747
Puma Biotechnology
PBYI
$404M
| $5.26M | 0.02% |
22,048
+444
| +2% | +$91.2K |
|
|
FEIC
748
DELISTED
FEI COMPANY
FEIC
| $5.25M | 0.02% |
69,578
+355
| +0.5% | +$29.9K |
|
749
Sensient Technologies
SXT
$5.26B
| $5.24M | 0.02% |
99,991
-920
| -0.9% | -$50.1K |
|
|
PAY
750
DELISTED
Verifone Systems Inc
PAY
| $5.23M | 0.02% |
152,191
+2,467
| +2% | +$86.8K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2014 Portfolio in Review
As of Q3 2014, RhumbLine Advisers held 3,039 positions worth $33.3B, down 2.3% from $34.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q3 2014: portfolio turnover was 2.8%. RhumbLine Advisers opened 28 new positions and exited 57, leaving the 3,039-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 346,925 shares worth $12.9M.
- RhumbLine Advisers added most to Allergan plc in Q3 2014, an estimated $29M increase.
- RhumbLine Advisers's biggest Q3 2014 reduction was Apple, cutting an estimated $34.4M.
- RhumbLine Advisers fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $32.2M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $33.3B portfolio in Q3 2014.
- RhumbLine Advisers opened 28 new positions and closed 57 in Q3 2014.
- RhumbLine Advisers's portfolio value fell 2.3% quarter-over-quarter to $33.3B.
Based on RhumbLine Advisers's 13F filing for Q3 2014, filed 12 Nov 2014.